Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

Cited by (662)

Items 401–500 of 662

1. Promoting effect of triterpenoid compound from Agrimonia pilosa Ledeb on preadipocytes differentiation via up-regulation of PPARγ expression
   Liancai Zhu, Bochu Wang, Tingwang Guo, Jun Tan, Xuemei Zhou, Ling Zhi XIAO, Xi Liu · 2015 · Pharmacognosy Magazine
2. Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes
   Marie Louise Johansen, Morten Schou, Jon Rasmussen, Patrick Rossignol, Maria Refsgaard Holm, Elizaveta Chabanova, Flemming Dela, Jens Oscar Faber, Caroline Kistorp · 2018 · Diabetes & Metabolism
3. Pathogenesis of Type 2 Diabetes Mellitus
   Ralph Anthony DeFronzo · 2018 · Endocrinology
4. The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus
   Juraj Koška, Emilio Ortega, Clifton Bogardus, Jonathan A. Krakoff, Joy C. Bunt · 2007 · American Journal of Physiology-Endocrinology and Metabolism
5. Clinical update on non-alcoholic fatty liver disease and steatohepatitis
   Elisabetta Bugianesi, Stefano Bellentani, Giorgio Bedogni, Claudio Tiribelli · 2008 · Annals of Hepatology
6. Pathogenesis of type 2 diabetes mellitus
   Ralph A. DeFronzo · 2015 · Wiley eBooks
7. Insulin resistance and overweight-obese women with polycystic ovary syndrome
   Sudhindra Mohan Bhattacharya · 2009 · Gynecological Endocrinology
8. The status of diabetes and its complications in Latin-American population: A review article
   Ricardo Rafael Correa, Sri Harsha Tella, Ghada Elshimy, Jaime A. Davidson · 2020 · Diabetes Research and Clinical Practice
9. Fatty liver and chronic inflammation in Chinese adults
   Pei‐Wen Wang, Ching‐Jung Hsieh, Leung-Chit Psang, Yu‐Fan Cheng, Chia‐Wei Liou, Shao‐Wen Weng, Jung‐Fu Chen, I‐Ya Chen, Rong-Hwai Li, Hock‐Liew Eng · 2008 · Diabetes Research and Clinical Practice
10. Adiponectin is related to intramyocellular lipid content in non-diabetic adults
    Amélio F. Godoy‐Matos, Luciana Bahia, Romeu Côrtes Domingues, Fernando Lencastre Sicuro, Marcos Antônio Tambascia, Bruno Geloneze, Luiz Guilherme Kraemer‐Aguiar, Eliete Bouskela · 2009 · Journal of Endocrinological Investigation
11. Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus
    Ji Yoon Kim, Ji Yoon Lee, Sin Gon Kim, Nam Hoon Kim · 2024 · Diabetes & Metabolism Journal
12. An adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis
    Renata Risi, Antonio Vidal‐Puig, Guillaume Bidault · 2024 · Journal of Endocrinology
13. Amorphastilbol exerts beneficial effects on glucose and lipid metabolism in mice consuming a high-fat-diet
    Woojung Lee, Jungyeob Ham, Hak Cheol Kwon, Goo Yoon, Gyu‐Un Bae, Yong Kee Kim, Su‐Nam Kim · 2015 · International Journal of Molecular Medicine
14. Ginseng and obesity: Observations from assorted perspectives
    Fayeza Md. Siraj, Yeon Ju Kim, Sathishkumar Natarajan, Seok Kyu Jung, Dong Uk Yang, Deok‐Chun Yang · 2014 · Food Science and Biotechnology
15. Pioglitazone, Bladder Cancer, and the Presumption of Innocence
    Georgios S. Papaetis · 2022 · Current Drug Safety
16. In vivo activity of 11β‐hydroxysteroid dehydrogenase type 1 and free fatty acid‐induced insulin resistance
    Knut Mai, Volker Kullmann, Thomas Bobbert, Christiane Maser‐Gluth, Matthias Möhlig, Volker Bähr, Andreas F. H. Pfeiffer, Joachim Spranger, S Diederich · 2005 · Clinical Endocrinology
17. Improving macrovascular outcomes in type 2 diabetes: outcome studies in cardiovascular risk and metabolic control
    C. Schneider · 2006 · Current Medical Research and Opinion
18. Effects of pioglitazone in familial combined hyperlipidaemia
    Evertine J. Abbink, Jacqueline d Graaf, Jacco H. de Haan, Arend Heerschap, Anton F. H. Stalenhoef, Cees J. Tack · 2005 · Journal of Internal Medicine
19. Immunomodulation through Nutrition Should Be a Key Trend in Type 2 Diabetes Treatment
    Katarzyna Napiórkowska-Baran, Paweł Treichel, Marta Czarnowska, Magdalena Drozd, Kinga Koperska, Agata Węglarz, Oskar Schmidt, Samira Darwish, Bartłomiej Szymczak, Zbigniew Bartuzi · 2024 · International Journal of Molecular Sciences
20. The Function of Myostatin in Ameliorating Bone Metabolism Abnormalities in Individuals with Type 2 Diabetes Mellitus by Exercise
    Chenghao Zhong, Xinyu Zeng, Xiaoyan Yi, Yuxin Yang, Jianbo Hu, Rongbin Yin, Xianghe Chen · 2025 · Current Issues in Molecular Biology
21. Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin‐treated T2DM patients: Results from the Qatar Study
    Muhammad A Abdul‐Ghani, Osama Migahid, Ayman Megahed, Rajvir Singh, Mohammad Fawaz, Ralph A. DeFronzo, Amin Jayyousi · 2018 · Diabetes Obesity and Metabolism
22. Age differences in the risk of diabetes incidence according to body mass index level in Japanese women
    Yukako Tatsumi, Yuko Ohno, Akiko Morimoto, Yoshio Nishigaki, Shoichi Mizuno, Shaw Watanabe · 2012 · Obesity Research & Clinical Practice
23. Circulating free fatty acids are increased independently of PPARγ activity after administration of poloxamer 407 to mice
    Thomas Patrick Johnston, David J. Waxman · 2008 · Canadian Journal of Physiology and Pharmacology
24. Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice
    Rasha Mosa, Lili Huang, Yeda Wu, Chungyan Fung, Oshini Mallawakankanamalage, Derek LeRoith, Chen Chen · 2017 · Endocrinology
25. Lipophagy: A New Perspective of Natural Products in Type 2 Diabetes Mellitus Treatment
    Mingyue Huang, Xinyu Yang, Zhenzhen Wang, Jianglan Long, Aiting Wang, Yi Zhang, Dan Yan · 2021 · Diabetes Metabolic Syndrome and Obesity
26. Oreocnide integrifolia (Gaud.) Miq leaf water extract improves metabolic alterations in high fructose fed insulin resistant and hypertensive rats
    Ansarullah, Bhavna Bharucha, Vaibhav B. Patel, A. V. Ramachandran · 2010 · European Journal of Integrative Medicine
27. The 6th Annual World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2009 · Diabetes Care
28. Pathogenesis of Type 2 Diabetes Mellitus
    Ralph Anthony DeFronzo · 2018 · Endocrinology
29. Chronic Tumor Necrosis Factor-α Infusion in Gravid C57BL6/J Mice Accelerates Adipose Tissue Development in Female Offspring
    Suzan Lambin, Rita van Bree, Ignace B. Vergote, Johan Verhaeghe · 2006 · Journal of the Society for Gynecologic Investigation
30. Associations of the Limb Fat to Trunk Fat Ratio With Markers of Cardiometabolic Risk in Elderly Men and Women
    Travis John Saunders, Lance E. Davidson, Peter M. Janiszewski, Jean‐Pierre Després, R. Hudson, R. Ross · 2009 · The Journals of Gerontology Series A
31. Rosiglitazone decreases intra‐ to extramyocellular fat ratio in obese non‐diabetic adults with metabolic syndrome
    Amélio F. Godoy‐Matos, Luciana Bahia, Romeu Côrtes Domingues, Marcos Antônio Tambascia, Bruno Geloneze, Luiz Guilherme Kraemer‐Aguiar, Eliete Bouskela · 2009 · Diabetic Medicine
32. Type 2 Diabetes Mellitus
    Adrian Po Zhu Li, Dulmini Kariyawasam · 2021 · Elsevier eBooks
33. Early-Phase Changes in Serum Free Fatty Acid Levels After Glucose Intake Are Associated With Type 2 Diabetes Incidence: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases
    Nobuo Sasaki, Ryo Maeda, Ryoji Ozono, Kenichi Yoshimura, Yukiko Nakano, Yukihito Higashi · 2022 · Diabetes Care
34. New Insight Into A1 Adenosine Receptors in Diabetes Treatment
    Marzena Wójcik, Andrzej Zieleniak, Lucyna A. Woźniak · 2010 · Current Pharmaceutical Design
35. Cistanches Herba reduces the weight gain in high fat diet-induced obese mice possibly through mitochondrial uncoupling
    Hoi Shan Wong, Jihang Chen, Pou Kuan Leong, Hoi Yan Leung, Wing Man Chan, Kam Ming Ko · 2014 · Journal of Functional Foods
36. Evaluation of body fat composition after linagliptin treatment in a rat model of diet‐induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine
    Thomas Klein, Heiko G. Niessen, Carina Ittrich, Eric Mayoux, H Mueller, Sharon C. Cheetham, Detlef Stiller, Jan Kassubek, Michael Mark · 2012 · Diabetes Obesity and Metabolism
37. Free fatty acid as a determinant of ischemic lesion volume in nonarterial-origin embolic stroke
    Jong‐Won Chung, Woo‐Keun Seo, Gyeong‐Moon Kim, Chin‐Sang Chung, Kwang Ho Lee, Oh Young Bang · 2017 · Journal of the Neurological Sciences
38. The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial
    Amirsalar Samkani, Mads Juul Skytte, Christian Anholm, Arne Vernon Astrup, Carolyn Fiona Deacon, Jens Juul Holst, Sten Madsbad, Ray Boston, Thure Krarup, Steen B. Haugaard · 2018 · Lipids in Health and Disease
39. Obesity Pillars Roundtable: Obesity and Diversity
    Harold Edward Bays, Doris X. Muñoz-Mantilla, Ryan Morgan, Chima Nwizu, Theresa “Tess” Garcia · 2022 · Obesity Pillars
40. Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs
    Ikuo Yokoyama, Yusuke Inoue, Toshiyuki Moritan, Kuni Ohtomo, Ryozo Nagai · 2006 · European Journal of Nuclear Medicine and Molecular Imaging
41. Advances in the development of AMPK-activating compounds
    Apiradee Sriwijitkamol, Nicolas Musi · 2008 · Expert Opinion on Drug Discovery
42. Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1‐year randomized study
    Marie‐Ève Piché, Anne‐Sophie Laberge, Patrice Brassard, Benoît J. Arsenault, Olivier Francois Bertrand, Jean‐Pierre Després, Olivier Costerousse, Paul Poirier · 2018 · Diabetes Obesity and Metabolism
43. Postprandial metabolomics: GC-MS analysis reveals differences in organic acid profiles of impaired fasting glucose individuals in response to highland barley loads
    Rui Liu, Jinhui Zhao, Jing Guo, Xiaowei Liu, Jiaying Yu, Hanming Wang, Ying Li, Changhao Sun, Liyan Liu · 2019 · Food & Function
44. The Melanocortin System as a Therapeutic Treatment Target for??Adiposity and Adiposopathy
    Harold Edward Bays · 2006 · Drugs in R&D
45. Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease
    Lorenzo Monti, Pietro Lucotti, Emanuela Setola, Alessandra Rossodivita, Maria Grazia Pala, Elena Galluccio, Giovanni La Canna, Alessandro Castiglioni, Marianna Cannoletta, C. Meloni et al. · 2010 · Nutrition Metabolism and Cardiovascular Diseases
46. Association of serum total fatty acids with type 2 diabetes
    Na Li, Yuming Qiu, Yunpeng Wu, Mo Zhang, Zhizhen Lai, Qing Wang, Yuying Du, Lei Guo, Shuai Liu, Zhili Li · 2019 · Clinica Chimica Acta
47. Thiazolidinediones (TZDs)
    Jong Chul Won · 2021 · Stroke revisited
48. Nonalcoholic Fatty Liver Disease
    Jeffrey B. Schwimmer · 2007 · Cambridge University Press eBooks
49. Update: metabolic and cardiovascular consequences of bariatric surgery.
    Donald W. Richardson, M. E. Mason, A. Vinik · 2011 · Endocrinology and metabolism clinics of North America (Print)
50. Angiotensin Receptor Blocker Telmisartan Improves Insulin Sensitivity in Peritoneal Dialysis Patients
    Antonio Cioni, Caterina Sordini, Ivo Cavallini, Roberto Bigazzi, Vito M. Campese · 2010 · Peritoneal Dialysis International
51. The effect of noise exposure on insulin sensitivity in mice may be mediated by the JNK/IRS1 pathway
    Lijie Liu, Cong Fang, Jingyu Yang, Hongyu Zhang, Yi Huang, Chuanying Xuan, Yongfang Wang, Shengwei Li, Jun Sha, Mingming Zha et al. · 2018 · Environmental Health and Preventive Medicine
52. Alterations in Body Weight, Blood Glucose Levels, and Lipid Profiles in High-Fat Diet-Low Dose Streptozotocin-Induced Diabetic Rats
    Raysa Yunda Pratiwi, Berna Elya, Heri Setiawan, Atini Solawati · 2021 · Pharmacognosy Journal
53. Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects
    R. Eldor, L. Norton, Marcel J. Fourcaudot, C. Galindo, R. DeFronzo, M. Abdul-Ghani · 2017 · PLoS ONE
54. Calcium deficiency in the early stages after weaning is associated with the enhancement of a low level of adrenaline-stimulated lipolysis and reduction of adiponectin release in isolated rat mesenteric adipocytes
    Aki Shinoki, Hiroshi Hara · 2009 · Metabolism
55. Adiposidad total, su distribución abdominal
    Ana Mary Fernández Milán, Daysi Antonia Navarro Despaigne · 2010 · Revista Cubana de Obstetricia y Ginecología
56. Patient-Oriented Research
    Ellen W. Seely, Steven Kyle Grinspoon · 2016 · Elsevier eBooks
57. Mesa redonda XXV. Adiposidad abdominal como factor de riesgo para enfermedades crónicas
    Carlos Alberto Aguilar-Salinas · 2007 · Salud Pública de México
58. What men should know about metabolic syndrome, adiposopathy and ‘sick fat’
    Harold Edward Bays, J. Michael González-Campoy, Alan Bruce Schorr · 2010 · International Journal of Clinical Practice
59. Regulation of Intermediatory Metabolism During Fasting and Feeding
    Ralph A. DeFronzo, Ele Ferrannini · 2010 · Elsevier eBooks
60. Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment
    Vedrana Ivić, Milorad Zjalić, Senka Blažetić, Matija Fenrich, Irena Labak, Rudolf Scitovski, Kálmán Ferenc Szűcs, Eszter Ducza, Tamás Tábi, Fruzsina Bagaméry et al. · 2023 · Frontiers in Endocrinology
61. Adipose Gene Expression Profiles Related to Metabolic Syndrome Using Microarray Analyses in Two Different Models
    Hye Jin Yoo, Hwan‐Jin Hwang, Tae Woo Jung, Ja Young Ryu, Ho Cheol Hong, Hae Yoon Choi, Sei Hyun Baik, Kyung Mook Choi · 2014 · Diabetes & Metabolism Journal
62. Pioglitazone in the management of Type 2 diabetes and beyond
    Harald Sourij, Thomas C. Wascher · 2007 · Therapy
63. Papel del tejido adiposo blanco en las complicaciones vasculares asociadas a la obesidad
    Almudena Gómez‐Hernández, Liliana Perdomo, Óscar Escribano, Manuel Benito · 2013 · Clínica e Investigación en Arteriosclerosis
64. Mechanisms Involved in Glycemic Control Promoted by Exercise in Diabetics
    Eric Francelino Andrade, Víviam de Oliveira Silva, Débora Ribeiro Orlando, Luciano José Pereira · 2018 · Current Diabetes Reviews
65. Cyclocarya paliurus (Batal.) Iljinskaja polysaccharides alleviate type 2 diabetes mellitus in rats by resisting inflammatory response and oxidative stress
    Wensheng YAN, Lingjun Jiang, Jifen XU · 2019 · Food Science and Technology
66. Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome
    Mira Aubuchon, Jennifer A. Bickhaus, Frank González · 2013 · Springer eBooks
67. The Metabolic Syndrome
    Neil B. Ruderman, Gerald I. Shulman · 2010 · Elsevier eBooks
68. Glucose: Metabolism and Regulation
    Evangelos Zoidis, Vasilios Papamikos · 2015 · Elsevier eBooks
69. Insulin actions in vivo : glucose metabolism
    Ele Ferrannini, Ralph A. DeFronzo · 2015 · Wiley eBooks
70. Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation
    Takumi Kitamoto, Hitoshi Watanabe, Yasutaka Miyachi, Makoto Miyabayashi, Li Qiang, Masahiko Ajiro, Akihide Yoshimi, Yoshiro Maezawa, Koutaro Yokote, Domenico Accili · 2025 · Diabetes
71. Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus
    Alsalt Al-Busaidi, Omer Alabri, Jaifar Alomairi, Ahmed Elsharaawy, Abdullah Al Lawati, Hanan Al Lawati, Srijit Das · 2024 · Current Diabetes Reviews
72. Inhibition of palmitic acid induced adipogenesis by natural polyphenols in 3T3-L1 adipocytes
    Cordelia Mano John, Sumathy Arockiasamy · 2022 · In Vitro Cellular & Developmental Biology - Animal
73. Effect of Insulin and Pioglitazone on Protein Phosphatase 2A Interaction Partners in Primary Human Skeletal Muscle Cells Derived from Obese Insulin-Resistant Participants
    Lana Alghanem, Xiangmin Zhang, Ruchi Jaiswal, Berhane Seyoum, Abdullah Mallisho, Zaher Msallaty, Zhengping Yi · 2022 · ACS Omega
74. Can pioglitazone be used for optimization of nutrition in critical illness? A systematic review
    Thomas J. McClelland, Alexander James Fowler, Thomas Davies, Rupert M. Pearse, John Richard Prowle, Zudin Puthucheary · 2023 · Journal of Parenteral and Enteral Nutrition
75. Effect of Feeding High-Fat with or Without Sucrose on the Development of Diabetes in Wistar Rats
    Shanmugam Sivabalan, Venugopal Padmanabhan Menon · 2008 · Asian Journal of Biochemistry
76. Serum palmitic acid–oleic acid ratio and the risk of coronary artery disease: a case-control study
    Ling-bing Sun, Yan Zhang, Qiang Wang, Hao Zhang, Wei Xu, Jie Zhang, Jie Xiang, Qing-guo Li, Yang Xiang, Dongjin Wang et al. · 2010 · The Journal of Nutritional Biochemistry
77. Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet
    Ying Han, Mihyang Do, Mi Sun Kim, Eunhui Seo, Mikyoung Park, Duk Kyu Kim, Hye‐Jeong Lee, Su‐Yeong Seo · 2010 · Korean Journal of Physiology and Pharmacology
78. Alcohol and Fat Promote Steatohepatitis: A Critical Role for Fat-Specific Protein 27/Cidec
    Suthat Liangpunsakul, Bin Gao · 2016 · Journal of Investigative Medicine
79. n-3 Polyunsaturated Fatty Acids in Type 2 Diabetes Mellitus
    Roxana Valdés‐Ramos, Ana Laura Guadarrama López, Beatriz Elina Martínez‐Carrillo, Laurence Steven Harbige · 2019 · Elsevier eBooks
80. Metabolic Syndrome
    Neil B. Ruderman, Gerald I. Shulman · 2015 · Elsevier eBooks
81. A Case of Acquired Generalized Lipodystrophy with Cerebellar Degeneration and Type 2 Diabetes Mellitus
    Pei-Jiuan Chao, Jack C.‐R. Tsai, Dao‐Ming Chang, Shyi‐Jang Shin, Yau‐Jiunn Lee · 2004 · The Review of Diabetic Studies
82. Effects of lifestyle and genetic factors on the levels of serum adiponectin, a novel marker of the metabolic syndrome, in Finnish servicemen
    Firoozeh Mousavinasab · 2007
83. The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK/PGC-1α/PPARα pathway
    Yu Tian, Dongxu Shi, Haiying Liao, Bi-Nan Lu, Zong-Ran Pang · 2023 · Diabetology & Metabolic Syndrome
84. Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter ‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial
    Min Yang, Yue Han, Qinqin Xu, Shiying Shao, Yong Chen · 2024 · Diabetes Obesity and Metabolism
85. Is there U-turn from Insulin Back to Pills in Diabetes?
    Sibel Ertek, Şevki Çetinkalp · 2014 · Current Vascular Pharmacology
86. The impact of the administration of red ginseng (Panax ginseng) on lipid metabolism and free fatty acid profiles in healthy horses using a molecular networking approach
    Young Beom Kwak, Hye Hyun Yoo, Jungho Yoon · 2024 · Frontiers in Veterinary Science
87. The Multiple Consequences of Obesity
    Indu Saxena, Amar Preet Kaur, Suwarna Suman, Abhilasha, Prasenjit Mitra, Praveen Sharma, Manoj Kumar · 2022 · IntechOpen eBooks
88. Anti-obesity effects of Camellia (Camellia oleifera Abel) oil treatment on high-fat diet-induced obesity in C57BL/6J mice
    Ramakrishna Chilakala, Hyeon Jeong Moon, Kiwoong Kim, Soyoung Yang, Sun Hee Cheong · 2023 · Physical Activity and Nutrition
89. Sitagliptin and metformin – novel combination therapy
    Berhane Seyoum · 2011 · Expert Opinion on Pharmacotherapy
90. Fatty Acids in Veterinary Medicine and Research
    Siobhan Simpson, A. Mostyn, Catrin Sian Rutland · 2017 · InTech eBooks
91. OBESIDAD: EPIDEMIA DEL NUEVO MILENIO
    Guido Lastra, Guido Lastra González · 2005 · DOAJ (DOAJ: Directory of Open Access Journals)
92. Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?
    Muhammad A Abdul‐Ghani, Ralph Anthony DeFronzo · 2021 · Expert Opinion on Pharmacotherapy
93. Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study
    Gozde Baskoy, Richard M Peterson, Jason W. Kempenich, Curtis L. Triplitt, Marissa Brown, Geoffrey D. Clarke, Eugênio Cersósimo, Andrew Mark, Olga Lavrynenko, Alberto Chavez-Velazquez et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
94. Fat Metabolism in Insulin Resistance and Type 2 Diabetes
    Hélène Duez, Gary F. Lewis · 2008 · Humana Press eBooks
95. Regulation ofLYRM1Gene Expression by Free Fatty Acids, Adipokines, and Rosiglitazone in 3T3-L1 Adipocytes
    Min Zhang, Hai-Ming Zhao, Zhen‐Ying Qin, Rui Qin, Xiao-Hui Chen, Yaping Zhao, Chunmei Zhang, Chunlin Gao, Chun Zhu, Chenbo Ji et al. · 2011 · Experimental Diabetes Research
96. 2nd International Symposium on Triglycerides and HDL
    Zachary T. Bloomgarden · 2005 · Diabetes Care
97. The Pathophysiology of Coronary Artery Disease
    Chantal M.C. Bassett, Richelle S. McCullough, Justin Deniset, rea Edel, rew Francis, Delfin Rodriguez–Leyva, Mirna N. Chahine, Grant N. Pierce · 2012 · CRC Press eBooks
98. Collagen overlays can inhibit leptin and adiponectin secretion but not lipid accumulation in adipocytes
    Sherri L. Christian, Nikitha K. Pallegar, Robert Brown, Alicia Viloria‐Petit · 2018 · PeerJ
99. The effects of flavonoid compound from Agrimonia pilosa Ledeb on promotting 3T3-L1 preadipocytes differentiation by activating PPARγ partially
    Liancai Zhu, Jun Tan, Deshuai Lou, Tingwang Guo, Bochu Wang · 2017 · Medicinal Chemistry Research
100. The role of metformin and pioglitazone in early combination treatment of type 2 diabetes mellitus
     Ian W. Campbell · 2006 · The British Journal of Diabetes